HLA Antigens and primary bronchial carcinoma
Open Access
- 15 June 1982
- Vol. 49 (12), 2485-2488
- https://doi.org/10.1002/1097-0142(19820615)49:12<2485::aid-cncr2820491212>3.0.co;2-c
Abstract
A comparative study of HLA, A, and B antigens frequency was undertaken on patients with primary bronchial carcinoma. A prospective study was carried out on 103 patients admitted for the first time to the hospital, and a retrospective study was done on 53 patients who survived at least five years. Forty‐seven patients died early while on the prospective study. The results show an increased frequency of B12 antigen both in patients of the prospective study and the retrospective study. This would suggest that the increase is associated with susceptibility to the disease rather than resistance to it. There was no finding in favor of an association between a HLA antigen and survival.This publication has 9 references indexed in Scilit:
- HL-A Antigens and Acute Lymphocytic Leukemia: The Nature of the HL-A2 AssociationTissue Antigens, 2008
- Hla type and survival in lung cancerCancer, 1980
- Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5:A two-year prospective studyCancer, 1977
- HLA Antigens in Bronchogenic CarcinomaOncology, 1977
- PROBABLE IDENTIFICATION OF AN HL-A SECOND-LOCUS ANTIGEN ASSOCIATED WITH A HIGH RISK OF NASOPHARYNGEAL CARCINOMAThe Lancet, 1975
- Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL‐A antigen profiles between patients and control groupsInternational Journal of Cancer, 1974
- HL‐A Antigens and Disease Statistical and Genetical ConsiderationsTissue Antigens, 1974
- Serological Studies on Lymphocytotoxic Antibodies in Primiparous WomenTissue Antigens, 1971
- GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKÆMOGENESISThe Lancet, 1964